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INTRODUCTION
Chronic sterile tissue inflammation [1] is the fundamental process that underlies dysfunction, injury and remodeling of tissues affected by common degenerative conditions like atherosclerosis, coronary artery disease and cerebrovascular disease. [1, 2] In diabetes, glucotoxic injury of the retina is associated with chronic retinal inflammation, which manifests as leukostasis, activation of microglia, vascular hyperpermeability and increased production of inflammatory mediators. [3] Several lines of evidence suggest that in the context of hyperglycemia, inflammatory responses may contribute to the degeneration of retinal capillaries which represents the first stage of microvascular remodeling in diabetic retinopathy (DR). [3] However, a critical amount of retinal capillary dropout, which would potentially result in tissue hypoxia and spontaneous preretinal neovascularization, has not yet been achieved in commonly used rodent models of DR. [3] Common causes of systemic inflammation, such as bacterial infection, have been linked in several instances to worsening of tissue dysfunction or injury in central nervous system (CNS) and cardiovascular degeneration. Specifically, systemic infections exacerbate neurodegenerative conditions such as Alzheimer's disease, and Parkinson's disease [4] and can increase the risk of stroke and coronary artery disease. [5] In diabetic patients, elevated circulating inflammatory markers correlate with microvascular complications, [6] including DR. [7] [8] [9] Furthermore, a small number of studies have suggested an association between distant infections and acceleration of DR. An increased risk of retinopathy has been reported in diabetic subjects with periodontal disease [10] and bacteriuria. [11] Rapid progression of DR has been reported in humans during West Nile virus infection [12] and after recovery from sepsis-related endophthalmitis [13, 14] but the mechanisms for this are unclear. Given the increasingly recognized importance of retinal inflammation in the pathophysiology of DR, together with the concept that infections exacerbate chronic illnesses in other organ systems, we saw the need to evaluate the potential of systemic sources of inflammation to accelerate the pathogenesis of DR. Accordingly, the aim of the present study was to evaluate the effects of systemic exposure to bacterial lipopolysaccharide (LPS) on inflammatory markers, vasculature and morphological integrity of the retina in 7-18 week old Ins2
Akita mouse model of background DR.
examined by epifluorescence microscopy (Olympus BX60, Tokyo, Japan) with 40x objective and the total number of adherent leukocytes per retina was determined. Epifluorescence microscopy was also employed to examine the Concanavalin-A stained microvasculature for evidence of microaneurysms or capillary dropout
Ex vivo analysis of endothelial injury
Acutely endotoxic mice and PBS controls were injected i.p. with 400µg of P.I. (Sigma-Aldrich, Castle Hill, NSW, Australia) in pyrogen-free saline, one hour preceding death and transcardial perfusion with FITCConcanavalin A as described above. The P.I. positive cells were quantified from whole retinal flatmounts using epifluorescence microscopy (n=7-10 mice/group) and x40 magnification, under 470-490nm excitation filter.
RT reaction and real-time quantitative PCR
Right and left retinae from individual mice were pooled into one sample per mouse. Total RNA was extracted using the RNeasy Mini Kit (Qiagen) and treated with DNAse I (Qiagen) according to manufacturer's instructions. The RNA was reverse-transcribed using the high capacity RNA-to-cDNA Kits Binary images of sample regions were generated and skeletonised using ImageJ software (v.1.44p, National
Institutes of Health, Bethesda, MD, USA), followed by a standard box-count analysis using the FracLac plugin (v2.5 Release 1e). Fractal dimensions were averaged for each mouse before statistical analysis.
Retinal thickness was measured at 300, 600 and 900µm from the optic cup employing B-scans of the nasal and temporal quadrant.All image manipulations were performed in a masked manner.
Statistical analysis. One-way ANOVA, followed by Bonferroni's Multiple Comparison Test at a 5% significance level was performed using GraphPad Prism Version 4.01 for Windows (GraphPad Software, San Diego, CA, USA). Data are presented as mean ± standard error of mean (SEM), except for blood glucose levels and glycosylated haemoglobin which are expressed as mean ± standard deviation (SD).
RESULTS

Effect of LPS on glycaemic status of Ins2 Akita mice
Non-fasting BGL (mmol/L) and HbA1c% were significantly higher in 7 week old Ins2 Akita -PBS injected mice than in WT-PBS injected littermates, consistent with the onset of hyperglycaemia ( Figure 1 A and Figure 1A and B respectively).
HbA1c% was unchanged between 18 week old WT-PBS and WT-LPS mice. Although pathologically elevated, mean HbA1c% in 18 week old Ins2 Akita mice which received three injections of LPS was significantly lower than HbA1c% in PBS-treated Ins2 Akita mice ( Figure 1C ).
Measurement of acute LPS-induced endothelial injury in early background DR
The use of P.I. fluorescence revealed injured or dead retinal endothelial cells, which typically presented as a 
Measurement of acute LPS-induced leukostasis in retinae of Ins2 Akita mice
The numbers of adherent retinal leukocytes per retina were similar in 7 week old PBS-treated WT and
Ins2
Akita mice (Figure 3 A, B, D, F). Twenty-four hours after LPS injection significant retinal leukostasis developed in both normoglycaemic WT and Ins2 Akita mice, in comparison to PBS-treated controls ( Figure 3C ,E,F). However, reactive leukostasis was significantly attenuated in LPS-treated Ins2 Akita mice, when compared to controls ( Figure 3F ). These results demonstrate that reactive retinal leukostasis develops in mice 24 hours after the i.p. injection of LPS, and that this response is subdued in diabetic mice which had been hyperglycaemic for around 3-4 weeks. 
Characterisation of the acute inflammatory response to i.p. LPS in retinae of
Effect of recurrent exposure to LPS on retinal thickness in early background DR
In vivo analysis of retinal thickness with OCT ( Figure 4A -C) revealed a significant but minor thinning of central retina in 18 week old Ins2 Akita mice after three doses of LPS spread over six weeks, two weeks after last injection, specifically at 300µm and 600µm distances from the optic cup, when compared to matching locations in LPS-treated normoglycaemic WT mice ( Figure 4D and 6E, respectively). Neither recurrent exposure to LPS in WT mice, nor 14 weeks of diabetes in PBS-treated Ins2 Akita mice significantly affected the total thickness of the central retina ( Figure 4D -F). Detailed nuclear counts, which were performed using high quality resin-embedded sections, did not reveal significant differences between the experimental groups (data not shown) reducing the likelihood of outer nuclear layers as sources of the thinning of total retina.
Recurrent LPS and capillary regression in early background DR
Retinal fluorescein angiograms and fractal analysis of the deep and intermediate capillary networks revealed no significant difference in in vessels between the four experimental groups ( Figure 5E-F) . There was no evidence of retinal leakage of fluorescein between these groups. No morphological differences were found on qualitative-post mortem assessment of Concanavalin A stained retinal microvasculature.
DISCUSSION
In light of the increasingly accepted concept that tissue inflammation plays a significant role in the pathogenesis of DR [3] we sought to test the hypothesis that systemic exposure to gram negative ultra-pure TLR4 specific endotoxin (LPS) would activate the innate inflammatory injury of the retina of diabetic
Ins2
Akita mice. Our data revealed that an acute (24 hours) response to systemic LPS caused greater retinal endothelial injury in diabetic Ins2 Akita mice than in identically treated WT littermates, which was associated with reactive LPS-leukostasis being suppressed in diabetic mice. Our data revealed a small but measurable thinning of the central retina in Ins2 Akita mice following repeated exposure to LPS.
Our findings of acute injury to the retinal endothelium in LPS-treated WT (C57BL6/J-Ins2
+ ) and Ins2
Akita mice support previous observations of LPS-induced endothelial injury in rat retina [20] and suggest that activation of TLR4-dependent innate immune responses causes focal retinal capillary damage in both the non-diabetic and diabetic retina. Importantly, in our study we noted a heightened susceptibility to acute LPS- Our study shows that adherent retinal leukocytes in the retina are similar in 7 week old PBS-treated WT and Ins2 Akita mice, with the latter group being hyperglycaemic for four weeks. These findings diverge from prior reports of significant retinal leukostasis developing within few days to weeks from the onset of hyperglycaemia in streptozotocin-induced rodent models of diabetes. [23, 24] However, the currently available literature does not clarify if streptozotocin contributes to retinal leukostasis per se or via the systemic toxicity including hepatotoxicity [25, 26] and nephrotoxicity. [27] It is also unclear if streptozotocin-insulitis involves a significant enough acute phase response that could trigger retinal leukostasis. By using a mouse model of spontaneous onset diabetes, like the Ins2 Akita mouse, these possible confounding effects of toxin-induced diabetes are excluded, which we believe is a strength of the present study.
The LPS-induced leukostasis we observed in Ins2 Akita mice was attenuated in comparison to LPS-treated WT mice, confirming previous findings of impaired leukostasis in streptozotocin-diabetic rats after systemic LPS. [28] Similar diminished response by leukocytes was observed in diabetic rat retina 24 hours after ischaemia reperfusion injury. [29] Our findings reinforce the notion that responses of leukocytes to inflammation or injury in diabetic retina are blunted, [28] however the relevant underlying mechanisms for this are unclear. Importantly, a range of abnormal leukocyte behaviours has been reported in non-ocular diabetic tissues, for instance decreased chemotactic responses of neutrophils to inflammatory mediators, impaired adhesion to the endothelium and increased apoptosis, [30] all changes that may underlie the attenuation of leukostasis after LPS-induced inflammation observed here and reperfusion injury reported previously in diabetic retina. [29] To our knowledge, this is the first study that has measured retinal Vegf transcript and protein after a relatively short history of diabetes in a mouse model with spontaneous onset of hyperglycaemia. Given the anti-apoptotic properties of VEGF, reduced expression of this factor could be involved in previously reported caspase activation in retinae of 8 week old Ins2 Akita mice. [16] Furthermore, our finding that expression of retinal VEGF is reduced acutely after LPS exposure in a healthy mouse corresponds to a previously reported decline in tissue expression of VEGF in the mouse brain, lung, kidney and spleen, 24
hours after systemic LPS. [31] In summary, the central hypothesis in this study was that diabetes would predispose the retina to acute and chronic injury from a mimic of systemic infection and that such injuries might accelerate the onset and progression of diabetic retinopathy. Our data reveals that LPS-induced systemic inflammation result in damage to retinal vessels and, if repeated, contributes to retinal thinning in mice with diabetic Ins2 Akita mice.
We confirm previous findings of abnormal reactive leukostasis in response to LPS in diabetic retina, indicating an altered inflammatory response. Subsequent studies will be required to evaluate if other triggers of innate inflammation (especially other TLR ligands) in the retina can more efficiently accelerate the background DR in mice, with the aim of producing a more advanced retinal pathology than what is found in current slowly progressing models. These studies are in progress. Further studies may also clarify if longer durations of hyperglycaemia and established tissue pathology predispose the retina to a more significant pathogen-mediated injury. 
